Namba N - Search Results

1

Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart.

Inagaki N, Tsuura Y, Namba N, Masuda K, Gonoi T, Horie M, Seino Y, Mizuta M, Seino S. Inagaki N, et al. Among authors: namba n. J Biol Chem. 1995 Mar 17;270(11):5691-4. doi: 10.1074/jbc.270.11.5691. J Biol Chem. 1995. PMID: 7890693 Free article.

2

Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.

Inagaki N, Gonoi T, Clement JP 4th, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J. Inagaki N, et al. Among authors: namba n. Science. 1995 Nov 17;270(5239):1166-70. doi: 10.1126/science.270.5239.1166. Science. 1995. PMID: 7502040

3

Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues.

Wang CZ, Namba N, Gonoi T, Inagaki N, Seino S. Wang CZ, et al. Among authors: namba n. Biochem Biophys Res Commun. 1996 Mar 7;220(1):196-202. doi: 10.1006/bbrc.1996.0380. Biochem Biophys Res Commun. 1996. PMID: 8602843

4

Kir2.2v: a possible negative regulator of the inwardly rectifying K+ channel Kir2.2.

Namba N, Inagaki N, Gonoi T, Seino Y, Seino S. Namba N, et al. FEBS Lett. 1996 May 20;386(2-3):211-4. doi: 10.1016/0014-5793(96)00445-0. FEBS Lett. 1996. PMID: 8647284 Free article.

5

Molecular basis of functional diversity of ATP-sensitive K+ channels.

Seino S, Inagaki N, Namba N, Wang CH, Kotake K, Nagashima K, Miki T, Aguilar-Bryan L, Bryan J, Gonoi T. Seino S, et al. Among authors: namba n. Jpn J Physiol. 1997;47 Suppl 1:S3-4. Jpn J Physiol. 1997. PMID: 9266305 Review. No abstract available.

6

The inwardly rectifying potassium channel subunit Kir2.2v (KCNJN1) maps to 17p11.2-->p11.1.

Namba N, Mori R, Tanaka H, Kondo I, Narahara K, Seino Y. Namba N, et al. Cytogenet Cell Genet. 1997;79(1-2):85-7. doi: 10.1159/000134688. Cytogenet Cell Genet. 1997. PMID: 9533018

7

Efficacy of growth hormone therapy for patients with skeletal dysplasia.

Kanazawa H, Tanaka H, Inoue M, Yamanaka Y, Namba N, Seino Y. Kanazawa H, et al. Among authors: namba n. J Bone Miner Metab. 2003;21(5):307-10. doi: 10.1007/s00774-003-0425-7. J Bone Miner Metab. 2003. PMID: 12928832 Clinical Trial.

8

Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial.

Namba N, Kubota T, Muroya K, Tanaka H, Kanematsu M, Kojima M, Orihara S, Kanda H, Seino Y, Ozono K. Namba N, et al. J Endocr Soc. 2022 Feb 11;6(5):bvac021. doi: 10.1210/jendso/bvac021. eCollection 2022 May 1. J Endocr Soc. 2022. PMID: 35356008 Free PMC article.

9

Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies.

Kubota T, Namba N, Tanaka H, Muroya K, Imanishi Y, Takeuchi Y, Kanematsu M, Sun W, Seino Y, Ozono K. Kubota T, et al. Among authors: namba n. Adv Ther. 2023 Apr;40(4):1530-1545. doi: 10.1007/s12325-022-02412-x. Epub 2023 Jan 31. Adv Ther. 2023. PMID: 36719566 Free PMC article.

10

Final adult height in long-term growth hormone-treated achondroplasia patients.

Harada D, Namba N, Hanioka Y, Ueyama K, Sakamoto N, Nakano Y, Izui M, Nagamatsu Y, Kashiwagi H, Yamamuro M, Ishiura Y, Ogitani A, Seino Y. Harada D, et al. Among authors: namba n. Eur J Pediatr. 2017 Jul;176(7):873-879. doi: 10.1007/s00431-017-2923-y. Epub 2017 May 13. Eur J Pediatr. 2017. PMID: 28501952 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters